← Scroll for more →
Financial Statements — INVZ
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 8.64 | 7.89 | 13.54 | 25.37 | 24.01 | 26.28 | 34.33 | 55.72 | 50.28 | 23.64 |
| Short-term Investments | 9.47 | 9.37 | 9.27 | 11.96 | 15.28 | 13.34 | 24.64 | 41.68 | 21.89 | 11.61 |
| Accounts Receivable | 9.98 | 19.81 | 11.62 | 6.04 | 5.42 | 7.40 | 2.38 | 1.76 | 1.08 | 0.51 |
| Inventory | 3.34 | 2.97 | 3.20 | 1.91 | 1.75 | 1.87 | 4.58 | 4.24 | 4.65 | 4.26 |
| Total Current Assets | 90.23 | 102.19 | 100.90 | 82.62 | 114.44 | 160.46 | 131.10 | 187.55 | 230.48 | 274.43 |
| Property, Plant & Equipment | 19.86 | 19.89 | 20.75 | 23.43 | 24.18 | 25.77 | 30.74 | 30.49 | 21.49 | 14.50 |
| Total Non-current Assets | 48.22 | 48.87 | 50.21 | 49.43 | 52.39 | 58.78 | 67.70 | 67.88 | 78.63 | 52.79 |
| Total Assets | 138.45 | 151.06 | 151.10 | 132.05 | 166.83 | 219.23 | 198.80 | 255.43 | 309.11 | 327.22 |
| Accounts Payable | 8.60 | 9.23 | 3.35 | 8.81 | 6.36 | 8.04 | 6.99 | 8.37 | 5.82 | 5.76 |
| Total Current Liabilities | 31.43 | 32.10 | 28.30 | 27.77 | 27.99 | 37.23 | 33.36 | 32.43 | 27.79 | 21.67 |
| Long-term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 |
| Total Non-current Liabilities | 29.31 | 29.30 | 29.68 | 25.35 | 26.10 | 28.72 | 28.71 | 30.98 | 31.37 | 6.75 |
| Total Liabilities* | 60.73 | 61.40 | 57.99 | 53.12 | 54.09 | 65.94 | 62.07 | 63.42 | 59.17 | 28.42 |
| Retained Earnings | (797.84) | (776.58) | (761.17) | (730.04) | (686.59) | (635.29) | (577.81) | (511.83) | (443.31) | (384.96) |
| Total Stockholder Equity | 77.72 | 89.67 | 93.12 | 78.93 | 112.74 | 153.29 | 136.73 | 192.02 | 249.95 | 298.80 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q3 2025 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|---|
| Total Revenue | 42.42 | 27.14 | 13.72 | 2.48 | 3.57 |
| Cost of Revenue | 31.58 | 18.60 | 15.26 | 9.57 | 6.08 |
| Gross Profit | 10.84 | 8.54 | (1.53) | (7.10) | (2.51) |
| Research & Development | 40.35 | 27.98 | 40.61 | 49.89 | 44.70 |
| Selling, General & Admin | 13.11 | 8.68 | 10.23 | 9.17 | 9.74 |
| Total Operating Expenses | 57.65 | 39.55 | 54.96 | 63.68 | 59.83 |
| Operating Income | (46.81) | (31.01) | (56.49) | (70.77) | (62.34) |
| Pretax Income | (46.42) | (31.04) | (51.23) | (65.51) | (58.30) |
| Tax Provision | 0.12 | 0.09 | 0.08 | 0.47 | 0.05 |
| Net Income | (46.54) | (31.12) | (51.30) | (65.97) | (58.35) |
| Basic EPS | (0.24) | (0.16) | (0.31) | (0.48) | (0.43) |
| Diluted EPS | (0.24) | (0.16) | (0.31) | (0.48) | (0.43) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q3 2025 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | (38.79) | (25.06) | (42.63) | (51.43) | (50.11) |
| Capital Expenditures | 3.21 | 2.92 | 2.03 | 5.14 | 5.03 |
| Free Cash Flow* | (42.00) | (27.98) | (44.66) | (56.57) | (55.13) |
| Investing Cash Flow | (26.16) | (25.39) | 40.30 | 29.61 | 77.39 |
| Financing Cash Flow | 46.42 | 37.55 | 0.11 | 0.23 | 0.29 |
← Scroll for more columns →
* Derived from reported values